Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 27, 2024
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
Michael Schmidt Maintained (BGNE) at Strong Buy with Decreased Target to $345 on, Feb 27th, 2024
Michael Schmidt of Guggenheim, Maintained "BeiGene, Ltd." (BGNE) at Strong Buy with Decreased Target from $350 to $345 on, Feb 27th, 2024.
Michael has made no other calls on BGNE in the last 4 months.
There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Jessica Fye of "JP Morgan" Initiated at Buy and Held Target at $185 on, Tuesday, February 6th, 2024
